blocking agent Search Results


protein band visualization  (Cytiva Europe)
94
Cytiva Europe protein band visualization
Protein Band Visualization, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/Amersham+ECL+blocking+agent/pmc05961033-481-5-11
Average 94 stars, based on 1 article reviews
protein band visualization - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier
fish gelatin blocking agent  (Biotium)
93
Biotium fish gelatin blocking agent
Fish Gelatin Blocking Agent, supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/Fish+Gelatin+Blocking+Agent/pm42907508-626-5-9
Average 93 stars, based on 1 article reviews
fish gelatin blocking agent - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
ecl prime western blot blocking agent  (GE Healthcare)
96
GE Healthcare ecl prime western blot blocking agent
Ecl Prime Western Blot Blocking Agent, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/Amersham+ECL+Blocking+Agent/10__2147_slash_ott__s251926-79-11-18
Average 96 stars, based on 1 article reviews
ecl prime western blot blocking agent - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier
blocking agent 2  (Meso Scale Diagnostics LLC)
90
Meso Scale Diagnostics LLC blocking agent 2
Blocking Agent 2, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/blocking+agent+2/us09803024-492-2-4
Average 90 stars, based on 1 article reviews
blocking agent 2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
sialix-sr-smsc-exos  (Sialix Inc)
90
Sialix Inc sialix-sr-smsc-exos
Sialix Sr Smsc Exos, supplied by Sialix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/blocking+agent/pm39890774-101-17-17
Average 90 stars, based on 1 article reviews
sialix-sr-smsc-exos - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
cardio selective beta-adrenergic receptor blocking agent  (alcon inc)
90
alcon inc cardio selective beta-adrenergic receptor blocking agent
Cardio Selective Beta Adrenergic Receptor Blocking Agent, supplied by alcon inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/cardio+selective+beta+adrenergic+receptor+blocking+agent/10__7554_slash_elife__84279-234-6-11
Average 90 stars, based on 1 article reviews
cardio selective beta-adrenergic receptor blocking agent - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
blocking agent block ace  (KAC Co Ltd)
90
KAC Co Ltd blocking agent block ace
Blocking Agent Block Ace, supplied by KAC Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/blocking+agent+block+ace/pm36562292-78-25-29
Average 90 stars, based on 1 article reviews
blocking agent block ace - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
blocking agent  (Arraystar inc)
90
Arraystar inc blocking agent
Blocking Agent, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/blocking+agent/pmc05716445-43-17-27
Average 90 stars, based on 1 article reviews
blocking agent - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
blocking agent block ace  (DS Pharma Biomedical)
90
DS Pharma Biomedical blocking agent block ace
Blocking Agent Block Ace, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/blocking+agent+block+ace/us10092642-266-33-39
Average 90 stars, based on 1 article reviews
blocking agent block ace - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
y27632  (Qilu Pharmaceutical)
90
Qilu Pharmaceutical y27632
BBB score of each group after 7 and 14 days of treatment. * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; ▵ P < 0.05 versus 7d Y-27632; ☆ P < 0.05 versus 14d EA; ▴ P < 0.05 versus 14d Y-27632. Data are expressed as the mean ± SD (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 16 or 8 rats/group). sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent <t>Y27632.</t>
Y27632, supplied by Qilu Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/blocking+agent+y27632/pmc08081320-133-8-11
Average 90 stars, based on 1 article reviews
y27632 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
universal blocking agent background sniper  (Biocare Medical)
90
Biocare Medical universal blocking agent background sniper
BBB score of each group after 7 and 14 days of treatment. * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; ▵ P < 0.05 versus 7d Y-27632; ☆ P < 0.05 versus 14d EA; ▴ P < 0.05 versus 14d Y-27632. Data are expressed as the mean ± SD (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 16 or 8 rats/group). sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent <t>Y27632.</t>
Universal Blocking Agent Background Sniper, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/universal+blocking+agent+background+sniper/pm22173567-69-24-28
Average 90 stars, based on 1 article reviews
universal blocking agent background sniper - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
punisher blocking agent  (Biocare Medical)
90
Biocare Medical punisher blocking agent
BBB score of each group after 7 and 14 days of treatment. * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; ▵ P < 0.05 versus 7d Y-27632; ☆ P < 0.05 versus 14d EA; ▴ P < 0.05 versus 14d Y-27632. Data are expressed as the mean ± SD (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 16 or 8 rats/group). sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent <t>Y27632.</t>
Punisher Blocking Agent, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocking+agent/punisher+blocking+agent/pm27629887-88-0-4
Average 90 stars, based on 1 article reviews
punisher blocking agent - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


BBB score of each group after 7 and 14 days of treatment. * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; ▵ P < 0.05 versus 7d Y-27632; ☆ P < 0.05 versus 14d EA; ▴ P < 0.05 versus 14d Y-27632. Data are expressed as the mean ± SD (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 16 or 8 rats/group). sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent Y27632.

Journal: The Journal of Spinal Cord Medicine

Article Title: The mechanism of electroacupuncture for treating spinal cord injury rats by mediating Rho/Rho-associated kinase signaling pathway

doi: 10.1080/10790268.2019.1665612

Figure Lengend Snippet: BBB score of each group after 7 and 14 days of treatment. * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; ▵ P < 0.05 versus 7d Y-27632; ☆ P < 0.05 versus 14d EA; ▴ P < 0.05 versus 14d Y-27632. Data are expressed as the mean ± SD (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 16 or 8 rats/group). sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent Y27632.

Article Snippet: Rats in the Y27632 treatment group received the blocking agent Y27632 (Qilu Pharmaceutical Co., Ltd., Jinan, Shandong Province, China) by subdural injection via a microinjector from a homemade PE10 tube (the 18 μg, 18 μg Y27632 lyophilized powders were dissolved in 30 μL phosphate buffered saline solution; each rat received 0.54 mL/kg), once per day, lasting for 14 days.8.

Techniques: Blocking Assay

Activity of cPLA2 and level of PGE2 following SCI. (A) Compiled results in a bar graph for the activity of cPLA2 at 7 and 14 days after treatment. (B) Compiled results in a bar graph for the level of PGE2 at 7 and 14 days after treatment. & P < 0.05 versus 7d sham; ^ P < 0.05 versus 14d sham; * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; △ P < 0.05 versus 7d Y-27632; ☆ P < 0.05 versus 14d EA; ▴ P < 0.05 versus 14d Y-27632. Data are shown as the mean ± standard error of the mean (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 8 rats/group). sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent Y27632.

Journal: The Journal of Spinal Cord Medicine

Article Title: The mechanism of electroacupuncture for treating spinal cord injury rats by mediating Rho/Rho-associated kinase signaling pathway

doi: 10.1080/10790268.2019.1665612

Figure Lengend Snippet: Activity of cPLA2 and level of PGE2 following SCI. (A) Compiled results in a bar graph for the activity of cPLA2 at 7 and 14 days after treatment. (B) Compiled results in a bar graph for the level of PGE2 at 7 and 14 days after treatment. & P < 0.05 versus 7d sham; ^ P < 0.05 versus 14d sham; * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; △ P < 0.05 versus 7d Y-27632; ☆ P < 0.05 versus 14d EA; ▴ P < 0.05 versus 14d Y-27632. Data are shown as the mean ± standard error of the mean (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 8 rats/group). sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent Y27632.

Article Snippet: Rats in the Y27632 treatment group received the blocking agent Y27632 (Qilu Pharmaceutical Co., Ltd., Jinan, Shandong Province, China) by subdural injection via a microinjector from a homemade PE10 tube (the 18 μg, 18 μg Y27632 lyophilized powders were dissolved in 30 μL phosphate buffered saline solution; each rat received 0.54 mL/kg), once per day, lasting for 14 days.8.

Techniques: Activity Assay, Blocking Assay

Effect of EA on changes in mRNA and protein expression levels of RhoA and ROCKII of injured spinal cords. (A,B) Western blotting bands for RhoA, ROCKII and GAPDH in different groups at 7 and 14 days. (C) Compiled results in a bar graph for RhoA protein expression. (D) Compiled results in a bar graph for ROCKII protein expression. (E) Compiled results in a bar graph for RhoA mRNA expression. (F) Compiled results in a bar graph for ROCKII mRNA expression. Y-axis indicates the relative grayscale value of protein bands (the ratio of target grayscale values to loading control grayscale values). & P < 0.05 versus 7d sham; ^ P < 0.05 versus 14d sham; * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; △ P < 0.05 versus 7d Y-27632; ☆ P < 0.05 versus 14d EA; ▴ P < 0.05 versus 14d Y-27632. Data are expressed as the mean ± SD (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 4 rats/group). sham: sham operation; SCI:SCI; EA:electroacupuncture; Y:blocking agent Y27632. ROCKII: RhoAssociated kinase II. GAPDH: glyceraldehyde-3-phosphate dehydrogenase.

Journal: The Journal of Spinal Cord Medicine

Article Title: The mechanism of electroacupuncture for treating spinal cord injury rats by mediating Rho/Rho-associated kinase signaling pathway

doi: 10.1080/10790268.2019.1665612

Figure Lengend Snippet: Effect of EA on changes in mRNA and protein expression levels of RhoA and ROCKII of injured spinal cords. (A,B) Western blotting bands for RhoA, ROCKII and GAPDH in different groups at 7 and 14 days. (C) Compiled results in a bar graph for RhoA protein expression. (D) Compiled results in a bar graph for ROCKII protein expression. (E) Compiled results in a bar graph for RhoA mRNA expression. (F) Compiled results in a bar graph for ROCKII mRNA expression. Y-axis indicates the relative grayscale value of protein bands (the ratio of target grayscale values to loading control grayscale values). & P < 0.05 versus 7d sham; ^ P < 0.05 versus 14d sham; * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; △ P < 0.05 versus 7d Y-27632; ☆ P < 0.05 versus 14d EA; ▴ P < 0.05 versus 14d Y-27632. Data are expressed as the mean ± SD (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 4 rats/group). sham: sham operation; SCI:SCI; EA:electroacupuncture; Y:blocking agent Y27632. ROCKII: RhoAssociated kinase II. GAPDH: glyceraldehyde-3-phosphate dehydrogenase.

Article Snippet: Rats in the Y27632 treatment group received the blocking agent Y27632 (Qilu Pharmaceutical Co., Ltd., Jinan, Shandong Province, China) by subdural injection via a microinjector from a homemade PE10 tube (the 18 μg, 18 μg Y27632 lyophilized powders were dissolved in 30 μL phosphate buffered saline solution; each rat received 0.54 mL/kg), once per day, lasting for 14 days.8.

Techniques: Expressing, Western Blot, Blocking Assay

mRNA expression of RhoA and ROCKII in injured spinal cords at 7 and 14 days. In situ hybridization positive cells contain brown spot or particles as indicated by the arrows. sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent Y27632; ROCK II: Rho-associated kinase II. (A) mRNA expression of Rho-A at 7 days; (B) mRNA expression of RhoA at 14 days; (C) mRNA expression of ROCKII at 7 days; (D) mRNA expression of ROCKII at 14 days. (n = 4 rats/group).

Journal: The Journal of Spinal Cord Medicine

Article Title: The mechanism of electroacupuncture for treating spinal cord injury rats by mediating Rho/Rho-associated kinase signaling pathway

doi: 10.1080/10790268.2019.1665612

Figure Lengend Snippet: mRNA expression of RhoA and ROCKII in injured spinal cords at 7 and 14 days. In situ hybridization positive cells contain brown spot or particles as indicated by the arrows. sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent Y27632; ROCK II: Rho-associated kinase II. (A) mRNA expression of Rho-A at 7 days; (B) mRNA expression of RhoA at 14 days; (C) mRNA expression of ROCKII at 7 days; (D) mRNA expression of ROCKII at 14 days. (n = 4 rats/group).

Article Snippet: Rats in the Y27632 treatment group received the blocking agent Y27632 (Qilu Pharmaceutical Co., Ltd., Jinan, Shandong Province, China) by subdural injection via a microinjector from a homemade PE10 tube (the 18 μg, 18 μg Y27632 lyophilized powders were dissolved in 30 μL phosphate buffered saline solution; each rat received 0.54 mL/kg), once per day, lasting for 14 days.8.

Techniques: Expressing, In Situ Hybridization, Blocking Assay

HE and Nissl staining in each group. Neuron cell was indicated by the black arrows, and neuroglia cell was indicated by the white arrows in HE staining and by the red arrows in Nissl staining. (A,B) HE staining at 7 days; (C,D): HE staining at 14 days; (E) Nissl staining at 7 days; (F) Nissl staining at 14 days. (n = 4 rats/group) sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent Y27632.

Journal: The Journal of Spinal Cord Medicine

Article Title: The mechanism of electroacupuncture for treating spinal cord injury rats by mediating Rho/Rho-associated kinase signaling pathway

doi: 10.1080/10790268.2019.1665612

Figure Lengend Snippet: HE and Nissl staining in each group. Neuron cell was indicated by the black arrows, and neuroglia cell was indicated by the white arrows in HE staining and by the red arrows in Nissl staining. (A,B) HE staining at 7 days; (C,D): HE staining at 14 days; (E) Nissl staining at 7 days; (F) Nissl staining at 14 days. (n = 4 rats/group) sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent Y27632.

Article Snippet: Rats in the Y27632 treatment group received the blocking agent Y27632 (Qilu Pharmaceutical Co., Ltd., Jinan, Shandong Province, China) by subdural injection via a microinjector from a homemade PE10 tube (the 18 μg, 18 μg Y27632 lyophilized powders were dissolved in 30 μL phosphate buffered saline solution; each rat received 0.54 mL/kg), once per day, lasting for 14 days.8.

Techniques: Staining, Blocking Assay

Phosphorylated myosin light chain(p-MLC) and MLC activation following SCI. (A,B) Western blotting bands for p-MLC, MLC and GAPDH in different groups at 7 and 14 days. (C) Compiled results in a bar graph for the ratio of p-MLC/GAPDH expression. (D) Compiled results in a bar graph for the ratio of MLC/GAPDH expression. (E) Compiled results in a bar graph for the ratio of p-MLC/MLC. & P < 0.05 versus 7d sham; ^ P < 0.05 versus 14d sham; * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; ☆ P < 0.05 versus 14d EA. Data are shown as the mean ± standard error of the mean (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 4 rats/group). sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent Y27632. MLC: myosin light chain. p-MLC: phosphorylated MLC. GAPDH: glyceraldehyde-3-phosphate dehydrogenase.

Journal: The Journal of Spinal Cord Medicine

Article Title: The mechanism of electroacupuncture for treating spinal cord injury rats by mediating Rho/Rho-associated kinase signaling pathway

doi: 10.1080/10790268.2019.1665612

Figure Lengend Snippet: Phosphorylated myosin light chain(p-MLC) and MLC activation following SCI. (A,B) Western blotting bands for p-MLC, MLC and GAPDH in different groups at 7 and 14 days. (C) Compiled results in a bar graph for the ratio of p-MLC/GAPDH expression. (D) Compiled results in a bar graph for the ratio of MLC/GAPDH expression. (E) Compiled results in a bar graph for the ratio of p-MLC/MLC. & P < 0.05 versus 7d sham; ^ P < 0.05 versus 14d sham; * P < 0.05 versus 7d SCI; # P < 0.05 versus 14d SCI; ☆ P < 0.05 versus 7d EA; ☆ P < 0.05 versus 14d EA. Data are shown as the mean ± standard error of the mean (two-way analysis of variance and Student–Newman–Keuls post hoc test, n = 4 rats/group). sham: sham operation; SCI: SCI; EA: electroacupuncture; Y: blocking agent Y27632. MLC: myosin light chain. p-MLC: phosphorylated MLC. GAPDH: glyceraldehyde-3-phosphate dehydrogenase.

Article Snippet: Rats in the Y27632 treatment group received the blocking agent Y27632 (Qilu Pharmaceutical Co., Ltd., Jinan, Shandong Province, China) by subdural injection via a microinjector from a homemade PE10 tube (the 18 μg, 18 μg Y27632 lyophilized powders were dissolved in 30 μL phosphate buffered saline solution; each rat received 0.54 mL/kg), once per day, lasting for 14 days.8.

Techniques: Activation Assay, Western Blot, Expressing, Blocking Assay